News
-
-
-
-
-
-
-
-
PRESS RELEASE
Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris
Bausch Health Canada signs agreement with pCPA for PrCABTREO gel to be covered by Canadian public drug plans. CABTREO is a triple-combination topical treatment for acne vulgaris -
-
PRESS RELEASE
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Salix Pharmaceuticals launches an authentic storytelling campaign 'IBS Symptoms Aren't Black and White: Living in the Gray', aiming to raise awareness and destigmatize irritable bowel syndrome (IBS) through patient stories on LinkedIn